- 商品介绍
- 规格参数
- 包装参数
规格 |
|
Accession Number: | NM_004720 |
Assay Entry: | Cell-based beta-arrestin recruitment |
Cell Line: | U2OS |
Cell State: | Dividing Cells |
Cytoplasmic Tail: | Tail from AVPR2 GPCR |
Druggable Target: | GPCRs |
Gene Symbol: | EDG4 |
Population Status: | Pool of Stable Cells |
Product Line: | Tango™ |
Reporter Gene: | BLA (Beta-Lactamase) |
System Type: | Tango™ |
Target Entry: | EDG4 |
Detection Method: | Fluorescent |
储存 |
|
(LiveBLAzer™-FRET B/G Loading Kit, Solution D and other materials are required separately; please refer to the protocol). Includes: o Tango™ EDG4-bla U2OS cells o Tango™ EDG4-bla U2OS Assay Protocol o Certificate of Analysis The Tango™ EDG4-bla U2OS cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt. |
描述 |
The Tango™ EDG4-bla U2OS cells contain the human Endothelial Differentiation Gene 4 (EDG4) linked to a TEV protease site and a Gal4-VP16 transcription factor stably integrated into the Tango™ GPCR-bla U2OS parental cell line. This parental cell line stably expresses a beta-arrestin/TEV protease fusion protein and the beta-lactamase (bla) reporter gene under the control of a UAS response element.
The Tango™ EDG4-bla U2OS DA cells have been functionally validated for Z' factor and EC50 concentrations of LPA (18:1). In addition, Tango™ EDG4-bla U2OS cells have been tested for assay performance under variable conditions. These data are found in the Validation & Assay Performance Summary in the Manuals and Brochures section.
长度(mm) | |
宽度(mm) | |
高度(mm) | |
重量(kg) |